IMvigor010, a phase III study of adjuvant atezolizumab vs...

European Urology Supplements 2017 / 03 Vol. 16; Iss. 3

IMvigor010, a phase III study of adjuvant atezolizumab vs observation in patients (pts) with muscle-invasive urothelial carcinoma (UC)

Gschwend, J., Bellmunt, J., Castellano, D., Daneshmand, S., Hussain, M., Nishiyama, H., Powles, T., Degaonkar, V., Nguyen Duc, A., Culine, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(17)30278-6
Date:
March, 2017
File:
PDF, 217 KB
english, 2017
Conversion to is in progress
Conversion to is failed